42 CFR § 10.2 - Summary of 340B Drug Pricing Program.

---
identifier: "/us/cfr/t42/s10.2"
source: "ecfr"
legal_status: "authoritative_unofficial"
title: "42 CFR § 10.2 - Summary of 340B Drug Pricing Program."
title_number: 42
title_name: "Public Health"
section_number: "10.2"
section_name: "Summary of 340B Drug Pricing Program."
chapter_name: "PUBLIC HEALTH SERVICE, DEPARTMENT OF HEALTH AND HUMAN SERVICES"
subchapter_number: "A"
subchapter_name: "GENERAL PROVISIONS"
part_number: "10"
part_name: "340B DRUG PRICING PROGRAM"
positive_law: false
currency: "2026-04-05"
last_updated: "2026-04-05"
format_version: "1.1.0"
generator: "[email protected]"
authority: "Sec. 340B of the Public Health Service Act (42 U.S.C. 256b) (PHSA), as amended."
regulatory_source: "82 FR 1229, Jan. 5, 2017, unless otherwise noted."
cfr_part: "10"
---


# 10.2 Summary of 340B Drug Pricing Program.

Section 340B of the PHSA instructs the Secretary of Health and Human Services to enter into agreements with manufacturers of covered outpatient drugs under which the amount to be paid to manufacturers by certain statutorily-defined covered entities does not exceed the 340B ceiling price.